Works matching IS 02692813 AND DT 2022 AND VI 55 AND IP 12

Results: 13

Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition. Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1590, doi. 10.1111/apt.16966
By:
- Goodoory, Vivek C.;
- Ng, Cho Ee;
- Black, Christopher J.;
- Ford, Alexander C.
Publication type:
Article
The efficacy and safety of keverprazan, a novel potassium‐competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double‐blind multicentre study.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1524, doi. 10.1111/apt.16959
By:
- Chen, Songfeng;
- Liu, Deliang;
- Chen, Honghui;
- Liao, Aijun;
- Li, Fangfang;
- Liu, Chengxia;
- Li, Xing;
- Li, Shengbao;
- Zhang, Yan;
- Wang, Yang;
- Xia, Min;
- Guo, Qinghong;
- Miao, Xinpu;
- Wen, Zhili;
- Xu, Min;
- Yin, Hekun;
- Chen, Huixin;
- Chen, Minhu;
- Xiao, Yinglian
Publication type:
Article
Editorial: estimating the costs of care in irritable bowel syndrome—a necessary step to enhance value‐based care for a high‐prevalence, low‐cost condition.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1588, doi. 10.1111/apt.16956
By:
- Berinstein, Jeffrey A.;
- Fendrick, A. Mark
Publication type:
Article
Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1512, doi. 10.1111/apt.16953
By:
- Byrne, Christopher J.;
- Radley, Andrew;
- Inglis, Sarah K.;
- Beer, Lewis;
- Palmer, Nicki;
- Duc Pham, Minh;
- Allardice, Kate;
- Wang, Huan;
- Robinson, Emma;
- Hermansson, Monika;
- Semizarov, Dimitri;
- Healy, Brendan;
- Doyle, Joseph S.;
- Dillon, John F.
Publication type:
Article
Systematic review—pancreatic involvement in inflammatory bowel disease.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1478, doi. 10.1111/apt.16949
By:
- Massironi, Sara;
- Fanetti, Ilaria;
- Viganò, Chiara;
- Pirola, Lorena;
- Fichera, Maria;
- Cristoferi, Laura;
- Capurso, Gabriele;
- Invernizzi, Pietro;
- Danese, Silvio
Publication type:
Article
Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1501, doi. 10.1111/apt.16934
By:
- Lövdahl, Jenny;
- Törnblom, Hans;
- Ringström, Gisela;
- Palsson, Olafur S.;
- Simrén, Magnus
Publication type:
Article
Review article: rethinking the "ladder" approach to reflux‐like symptom management in the era of PPI "resistance" ‐ a multidisciplinary perspective.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1492, doi. 10.1111/apt.16930
By:
- Hungin, A. Pali S.;
- Scarpignato, Carmelo;
- Keefer, Laurie;
- Corsetti, Maura;
- Anastasiou, Foteini;
- Muris, Jean W. M.;
- Mendive, Juan M.;
- Kahrilas, Peter J.
Publication type:
Article
Carvedilol versus endoscopic band ligation for secondary prophylaxis of variceal bleeding—long‐term follow‐up of a randomised control trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1581, doi. 10.1111/apt.16901
By:
- Dunne, Philip D. J.;
- Young, David;
- Chuah, Cher Shiong;
- Hayes, Peter C.;
- Tripathi, Dhiraj;
- Leithead, Joanna;
- Smith, Lyn A.;
- Gaya, Daniel R.;
- Forrest, Ewan;
- Stanley, Adrian J.
Publication type:
Article
Model to predict on‐treatment restoration of functional HBV‐specific CD8<sup>+</sup> cell response foresees off‐treatment HBV control in eAg‐negative chronic hepatitis B.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1545, doi. 10.1111/apt.16850
By:
- Peña‐Asensio, Julia;
- Calvo, Henar;
- Miquel, Joaquín;
- Sanz‐de‐Villalobos, Eduardo;
- González‐Praetorius, Alejandro;
- Torralba, Miguel;
- Larrubia, Juan‐Ramón
Publication type:
Article
Issue Information.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1475, doi. 10.1111/apt.16422
Publication type:
Article
Lower effectiveness of intravenous steroid treatment for moderate‐to‐severe ulcerative colitis in hospitalised patients with older onset: a multicentre cohort study.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1569, doi. 10.1111/apt.16865
By:
- Okabayashi, Shinji;
- Yamazaki, Hajime;
- Tominaga, Keiichi;
- Miura, Miki;
- Sagami, Shintaro;
- Matsuoka, Katsuyoshi;
- Yamaguchi, Yoshiharu;
- Noake, Toshihiro;
- Ozeki, Keiji;
- Miyazaki, Ryosuke;
- Kamano, Toshiaki;
- Fukuda, Tomohiro;
- Yoshioka, Kyoko;
- Ando, Katsuyoshi;
- Fukuzawa, Masakatsu;
- Andoh, Akira;
- Yamamoto, Yosuke;
- Hibi, Toshifumi;
- Kobayashi, Taku
Publication type:
Article
Defining normal pouch function in patients with ileal pouch‐anal anastomosis: a pilot study.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1560, doi. 10.1111/apt.16859
By:
- Quinn, Kevin P.;
- Busciglio, Irene A.;
- Burton, Duane D.;
- Inoue, Akitoshi;
- Lee, Yong S.;
- Heiken, Jay P.;
- Sheedy, Shannon P.;
- Fletcher, Joel G.;
- Raffals, Laura E.
Publication type:
Article
Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: data from the open‐label, long‐term extension study, OCTAVE open.
Published in:
Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 12, p. 1534, doi. 10.1111/apt.16848
By:
- Panaccione, Remo;
- Abreu, Maria T.;
- Lazariciu, Irina;
- Mundayat, Rajiv;
- Lawendy, Nervin;
- Salese, Leonardo;
- Woolcott, John C.;
- Sands, Bruce E.;
- Chaparro, María
Publication type:
Article